By Dr. Mercola
Drugmaker GlaxoSmithKline has preliminarily agreed to a $3 billion settlement over the sales and marketing practices of several of its drugs, including the diabetes drug Avandia. >
Subscribe to:
Post Comments (Atom)
Posts
Comments
No comments:
Post a Comment